Company intelligence / Profile preview

BioBeats

Petach Tikva, Center District, Israelbio-beat.com ↗

Ownership: Private
Employees: ~37
Development stage: Commercial

Overview

BioBeat’s wearable devices are FDA-cleared and CE-marked for continuous non-invasive measurement of multiple vital signs including blood pressure. The technology has been adopted by hospitals and health systems for both inpatient and remote patient management. No clinical trial pipeline as the company provides a device/platform rather than therapeutics.

Therapeutic areas: OtherCardiovascular
Modalities: DeviceNon-pharmacological therapy (wearable sensor technology)
Industry: Physiological Monitoring

Partnerships

Nuvance HealthTampa General HospitalNorthwell HealthDiscovery Limited

Beyond the preview

Go deeper on BioBeats.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioBeats.

Explore the full profile